Mayne Pharma Group Ltd
ASX:MYX
Mayne Pharma Group Ltd
Cash Paid for Dividends
Mayne Pharma Group Ltd
Cash Paid for Dividends Peer Comparison
Competitive Cash Paid for Dividends Analysis
Latest Figures & CAGR of Competitors
Company | Cash Paid for Dividends | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Mayne Pharma Group Ltd
ASX:MYX
|
Cash Paid for Dividends
-AU$45.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Recce Pharmaceuticals Ltd
ASX:RCE
|
Cash Paid for Dividends
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Neuren Pharmaceuticals Ltd
ASX:NEU
|
Cash Paid for Dividends
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Botanix Pharmaceuticals Ltd
ASX:BOT
|
Cash Paid for Dividends
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Probiotec Ltd
ASX:PBP
|
Cash Paid for Dividends
-AU$5.3m
|
CAGR 3-Years
-16%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
N/A
|
|
C
|
Clarity Pharmaceuticals Ltd
ASX:CU6
|
Cash Paid for Dividends
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Mayne Pharma Group Ltd's Cash Paid for Dividends?
Cash Paid for Dividends
-45.3m
AUD
Based on the financial report for Jun 30, 2023, Mayne Pharma Group Ltd's Cash Paid for Dividends amounts to -45.3m AUD.